Comparing Wound Complications After Elective Abdominal Surgery Using Two Closure Techniques
Launched by AMERICAN UNIVERSITY OF BEIRUT MEDICAL CENTER · May 4, 2018
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different techniques for closing wounds after abdominal surgery, specifically looking at how these techniques affect complications like infections and hernias. The first technique is the traditional method, which uses larger stitches that are spaced further apart. The second is a newer technique that involves smaller stitches placed closer together. Researchers believe that using the new technique may lead to fewer complications and a better quality of life for patients after surgery.
To participate in this study, you need to be 18 years or older and undergoing elective surgery with a midline incision (a straight cut down the middle of the abdomen). If you choose to take part, you will be randomly assigned to receive either the traditional or new closure technique, and both you and the doctors assessing your recovery will not know which method you received to ensure a fair comparison. There are no expected risks for participants, and all personal information will be kept confidential. This trial aims to provide clearer evidence on the best way to close abdominal wounds, helping surgeons improve patient outcomes in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Signed Informed Consent
- • Undergoing an elective laparotomy through a midline incision
- • Undergoing a midline laparoscopic procedure (midline laparoscopic extraction site)
- Exclusion Criteria:
- • Emergency surgery
- • Laparotomy through an incision other than midline
- • Previous midline laparotomy
- • Presence of incisional or ventral hernia at time of laparotomy
- • Incisional hernia repair
- • Laparotomy surgery during pregnancy
About American University Of Beirut Medical Center
The American University of Beirut Medical Center (AUBMC) is a leading academic medical institution in the Middle East, dedicated to advancing healthcare through innovative research, education, and clinical excellence. As a prominent sponsor of clinical trials, AUBMC integrates cutting-edge scientific inquiry with patient-centered care to enhance therapeutic options and improve health outcomes. With a commitment to ethical standards and regulatory compliance, AUBMC collaborates with multidisciplinary teams to conduct rigorous trials that contribute to the global medical knowledge base and address critical health challenges in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beirut, , Lebanon
Patients applied
Trial Officials
Eman Sbaity, MD
Principal Investigator
American University of Beirut Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials